Differential inhibitory effect of a pyrazolopyran compound on human serine hydroxymethyltransferase-amino acid complexes

PRODRG: a tool for high-throughput crystallography of protein–ligand complexes

Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,815 · see citing works

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403 · see citing works

Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins

Llopis, J. L., McCaffery, J. M., Miyawaki, A., Farquhar, M. G., & Tsien, R. Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6803 · Cited by 1,133 · see citing works

Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis

Zhang, W. C., Shyh-Chang, N., Yang, H., Rai, A., Umashankar, S., Ma, S., Soh, B. S., Sun, L. L., Tai, B. C., Nga, M. E., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.050 · Cited by 660 · see citing works

Reversal of cytosolic one-carbon flux compensates for loss of the mitochondrial folate pathway

Ducker, G. S., Chen, L., Morscher, R. J., Ghergurovich, J. M., Esposito, M., Teng, X., Kang, Y., & Rabinowitz, J. D. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.016 · Cited by 419 · see citing works

Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma

Ducker, G. S., Ghergurovich, J. M., Mainolfi, N., Suri, V., Jeong, S. K., Hsin-Jung Li, S., Friedman, A., Manfredi, M. G., Gitai, Z., Kim, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706617114 · Cited by 261 · see citing works

SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis

Anderson, D. D., & Stover, P. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005839 · Cited by 199 · see citing works

Cloning of human cDNAs encoding mitochondrial and cytosolic serine hydroxymethyltransferases and chromosomal localization

Garrow, T. A., Brenner, A., Whitehead, V. M., Chen, X. N., Duncan, R., Korenberg, J. R., & Shane, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50286-1 · Cited by 179 · see citing works

5-Formyltetrahydrofolate polyglutamates are slow tight binding inhibitors of serine hydroxymethyltransferase

Stover, P. J., & Schirch, V. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52328-0 · Cited by 132 · see citing works

SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation

Paone, A., Marani, M., Fiascarelli, A., Rinaldo, S., Giardina, G., Contestabile, R., Paiardini, A., & Cutruzzolà, F. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.482 · Cited by 129 · see citing works

Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism

Cuyàs, E., Fernández‐Arroyo, S., Verdura, S., Garcia, R., Štursa, J., Werner, L., Blanco‐González, E., Montes‐Bayón, M., Joven, J., Viollet, B., et al. (2017) · Oncogene · doi:10.1038/onc.2017.367 · Cited by 120 · see citing works

How pyridoxal 5′‐phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state

Giardina, G., Brunotti, P., Fiascarelli, A., Cicalini, A., Costa, M. G. S., Buckle, A. M., di Salvo, M. L., Giorgi, A., Marani, M., Paone, A., et al. (2015) · FEBS Journal · doi:10.1111/febs.13211 · Cited by 104 · see citing works

l ‐Threonine aldolase, serine hydroxymethyltransferase and fungal alanine racemase

Contestabile, R., Paiardini, A., Pascarella, S., di Salvo, M. L., D’Aguanno, S., & Bossa, F. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02606.x · Cited by 99 · see citing works

Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway

Ducker, G. S., Chen, L., Morscher, R. J., Ghergurovich, J. M., Esposito, M., Teng, X., Kang, Y., & Rabinowitz, J. D. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.011 · Cited by 91 · see citing works

Serine Transhydroxymethylase. Affinity of Tetrahydrofolate Compounds for the Enzyme and Enzyme-Glycine Complex*

Schirch, L., & Ropp, M. (1967) · Biochemistry · doi:10.1021/bi00853a039 · Cited by 86 · see citing works

The Role of Serine Hydroxymethyltransferase Isozymes in One-Carbon Metabolism in MCF-7 Cells as Determined by 13C NMR

Fu, T.-F., Rife, J. P., & Schirch, V. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2471 · Cited by 72 · see citing works

Measurement of cytosolic and mitochondrial pH in living cells during reversible metabolic inhibition

Balut, C., vandeVen, M., Despa, S. I., Lambrichts, I., Ameloot, M. M., Steels, P., & Smets, I. (2007) · Kidney International · doi:10.1038/sj.ki.5002632 · Cited by 70 · see citing works

The origin of reaction specificity in serine hydroxymethyltransferase.

Schirch, V., Shostak, K., Zamora, M., & Guatam-Basak, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35237-7 · Cited by 66 · see citing works

In silico and in vitro validation of serine hydroxymethyltransferase as a chemotherapeutic target of the antifolate drug pemetrexed

Daidone, F., Florio, R., Rinaldo, S., Contestabile, R., di Salvo, M. L., Cutruzzolà, F., Bossa, F., & Paiardini, A. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.009 · Cited by 64 · see citing works

Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT): Cocrystal Structures of Pyrazolopyrans with Potent Blood- and Liver-Stage Activities

Witschel, M. C., Rottmann, M., Schwab, A., Leartsakulpanich, U., Chitnumsub, P., Seet, M., Tonazzi, S., Schwertz, G., Stelzer, F., Mietzner, T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501987h · Cited by 63 · see citing works

A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells

Marani, M., Paone, A., Fiascarelli, A., Macone, A., Gargano, M., Rinaldo, S., Giardina, G., Pontecorvi, V., Koes, D. R., McDermott, L. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6726 · Cited by 57 · see citing works

Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming

Paiardini, A., Tramonti, A., Schirch, D., Guiducci, G., di Salvo, M. L., Fiascarelli, A., Giorgi, A., Maras, B., Cutruzzolà, F., & Contestabile, R. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.08.010 · Cited by 44 · see citing works

Serine hydroxymethyltransferase activity and serine incorporation in leukocytes.

Thorndike, J., Pelliniemi, T., & Beck, W. S. (1979) · PubMed · Cited by 39 · see citing works

Screening and In Vitro Testing of Antifolate Inhibitors of Human Cytosolic Serine Hydroxymethyltransferase

Paiardini, A., Fiascarelli, A., Rinaldo, S., Daidone, F., Giardina, G., Koes, D. R., Parroni, A., Montini, G., Marani, M., Paone, A., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500028 · Cited by 37 · see citing works

The mechanism of addition of pyridoxal 5′-phosphate to Escherichia coli apo-serine hydroxymethyltransferase

Malerba, F., Bellelli, A., Giorgi, A., Bossa, F., & Contestabile, R. (2007) · Biochemical Journal · doi:10.1042/bj20061681 · Cited by 30 · see citing works

Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold

Schwertz, G., Witschel, M. C., Rottmann, M., Leartsakulpanich, U., Chitnumsub, P., Jaruwat, A., Amornwatcharapong, W., Ittarat, W., Schäfer, A., Aponte, R. A., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800053 · Cited by 27 · see citing works

Human and Plasmodium serine hydroxymethyltransferases differ in rate-limiting steps and pH-dependent substrate inhibition behavior

Amornwatcharapong, W., Maenpuen, S., Chitnumsub, P., Leartsakulpanich, U., & Chaiyen, P. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.07.017 · Cited by 15 · see citing works

Site-Directed Mutagenesis Techniques in the Study ofEscherichia coliSerine Hydroxymethyltransferase

Iurescia, S., Condò, I., Angelaccio, S., Fratte, S. D., & Bossa, F. (1996) · Protein Expression and Purification · doi:10.1006/prep.1996.0046 · Cited by 14 · see citing works

A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight

Cuthbertson, C. R., Arabzada, Z., Bankhead, A., Kyani, A., & Neamati, N. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00223 · Cited by 57 · see citing works

The moonlighting RNA-binding activity of cytosolic serine hydroxymethyltransferase contributes to control compartmentalization of serine metabolism

Guiducci, G., Paone, A., Tramonti, A., Giardina, G., Rinaldo, S., Bouzidi, A., Magnifico, M. C., Marani, M., Menéndez, J. A., Fatica, A., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz129 · Cited by 56 · see citing works

Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT 2 by antifolate drugs

Scaletti, E. R., Jemth, A., Helleday, T., & Stenmark, P. (2019) · FEBS Letters · doi:10.1002/1873-3468.13455 · Cited by 52 · see citing works

Human Cytosolic and Mitochondrial Serine Hydroxymethyltransferase Isoforms in Comparison: Full Kinetic Characterization and Substrate Inhibition Properties

Tramonti, A., Nardella, C., di Salvo, M. L., Barile, A., Cutruzzolà, F., & Contestabile, R. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01074 · Cited by 37 · see citing works

Study of SHMT2 Inhibitors and Their Binding Mechanism by Computational Alanine Scanning

He, L., Bao, J., Yang, Y., Dong, S., Zhang, L., Qi, Y., & Zhang, J. Z. H. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00370 · Cited by 33 · see citing works

Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2

Tramonti, A., Cuyàs, E., Encinar, J. A., Pietzke, M., Paone, A., Verdura, S., Arbusà, A., Martı́n-Castillo, B., Giardina, G., Joven, J., et al. (2021) · Cancers · doi:10.3390/cancers13164009 · Cited by 31 · see citing works

Arabidopsis thaliana serine hydroxymethyltransferases: functions, structures, and perspectives

Nogués, I., Sekula, B., Angelaccio, S., Grzechowiak, M., Tramonti, A., Contestabile, R., & Ruszkowski, M. (2022) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2022.07.025 · Cited by 31 · see citing works

Upregulation of SHMT2 Promotes Tumor Growth and Poor Prognosis of Breast Cancer through Activating VEGF and MAPK Signaling PathwayPreprint

Xie, S.-Y., Shi, D., Ouyang, Y. Q., Cheng, X.-Y., Chen, X., Jiang, T., Xia, W., Guo, L., & Lin, H. (2021) · Research Square · doi:10.21203/rs.3.rs-1016628/v1 · Cited by 22 · see citing works

Mangiferin is a new potential antimalarial and anticancer drug for targeting serine hydroxymethyltransferase

Maenpuen, S., Mee-udorn, P., Pinthong, C., Athipornchai, A., Phiwkaow, K., Watchasit, S., Pimviriyakul, P., Rungrotmongkol, T., Tinikul, R., Leartsakulpanich, U., et al. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109712 · Cited by 22 · see citing works

Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies

Fultang, L., Gneo, L., Santo, C. D., & Mussai, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.674720 · Cited by 23 · see citing works

Transcriptomic and proteomic analysis of Staphylococcus aureus response to cuminaldehyde stress

Li, H., Huang, Y.-Y., Addo, K. A., Huang, Z.-X., Yu, Y.-G., & Xiao, X. (2022) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2022.109930 · Cited by 17 · see citing works

Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex

Spizzichino, S., Boi, D., Boumis, G., Lucchi, R., Liberati, F. R., Capelli, D., Montanari, R., Pochetti, G., Piacentini, R., Parisi, G., et al. (2021) · FEBS Journal · doi:10.1111/febs.16248 · Cited by 15 · see citing works

Phosphorylated SHMT2 Regulates Oncogenesis Through m6A Modification in Lung Adenocarcinoma

Han, T., Wang, Y., Cheng, M., Hu, Q., Wan, X., Huang, M.-L., Liu, Y., Xun, W., Xu, J., Wang, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202307834 · Cited by 14 · see citing works

Identification of three new compounds that directly target human serine hydroxymethyltransferase 2

Han, Y., He, L., Qi, Y., Zhao, Y., Pan, Y., Fang, B., Li, S., Zhang, J. Z. H., & Zhang, L. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13774 · Cited by 13 · see citing works

The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance

Jiang, Y., Zhou, G., Zhang, Q., & Zhou, S. (2026) · MedComm – Oncology · doi:10.1002/mog2.70062 · Cited by 1 · see citing works

Serine Hydroxymethyltransferase (SHMT) in biology and disease: molecular mechanisms and therapeutic targeting

Li, J.-Y., Zhang, X., & Sheng, R. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08044-x · Cited by 1 · see citing works

SHMT2 inhibition triggers mitochondrial apoptosis to suppress lung adenocarcinoma progression

Chen, Y., Zhang, X. H., Pang, X., Yang, Y., Lu, D., Zhao, J., Zhu, J., Du, W., Gu, C., Li, J., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07975-9

Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression

Li, M., Xu, Y. N., Su, X., & Wen, J. (2026) · PeerJ · doi:10.7717/peerj.21570

Human Cytosolic and Mitochondrial Serine Hydroxymethyltransferase Isoforms in Comparison: Full Kinetic Characterization and Substrate Inhibition Properties

Tramonti, A., Nardella, C., di Salvo, M. L., Barile, A., Cutruzzolà, F., & Contestabile, R. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01074 · Cited by 37 · see citing works

Identification of three new compounds that directly target human serine hydroxymethyltransferase 2

Han, Y., He, L., Qi, Y., Zhao, Y., Pan, Y., Fang, B., Li, S., Zhang, J. Z. H., & Zhang, L. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13774 · Cited by 13 · see citing works

A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells

Marani, M., Paone, A., Fiascarelli, A., Macone, A., Gargano, M., Rinaldo, S., Giardina, G., Pontecorvi, V., Koes, D. R., McDermott, L. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6726 · Cited by 57 · see citing works

Comparative binding and activity analysis of known serine hydroxymethyltransferase inhibitors in biochemical assays

Gräb, J., Wagner, C., Beber, C., Szczesny, J., Rubner, S., & Papasotiriou, I. (2026) · RSC Advances · doi:10.1039/d5ra08513f

Neutron crystallographic studies of crucial metabolic enzyme targeted by cancer

Drago, V. N., Phillips, R., & Kovalevsky, A. Y. (2025) · Structural Dynamics · doi:10.1063/4.0000414